Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review

Chaohe Zhang1, Jiyao Sheng1, Guangquan Li1

  • 1Jilin Provincial Key Laboratory on Molecular and Chemical Genetic, Second Hospital of Jilin University, Changchun, China.

Frontiers in Pharmacology
|February 4, 2020
PubMed

Insights

Berberine and its derivatives show anti-tumor effects. Further research into their mechanisms and safety could lead to new cancer therapies with better efficacy and fewer side effects.

Area of Science:

  • Pharmacology
  • Oncology
  • Natural Products Chemistry

Background:

  • Berberine and its derivatives are known for their anti-tumor properties.
  • The precise mechanisms underlying these anti-tumor effects require further elucidation.
  • Understanding these mechanisms is crucial for developing effective cancer treatments.

Purpose of the Study:

  • To systematically review the anti-tumor effects of berberine and its derivatives.
  • To explore the molecular, cellular, and organismic mechanisms of action.
  • To assess their potential as therapeutic agents in complex cancer treatment.

Main Methods:

  • Systems pharmacology approach.
  • Comprehensive literature review of existing studies.
  • Analysis of action and mechanisms at multiple biological levels.

Main Results:

  • Berberine and its derivatives exhibit significant anti-tumor activities.
  • Multiple molecular and cellular pathways are implicated in their anti-cancer effects.
  • Evidence suggests a broad spectrum of action against various cancer types.

Conclusions:

  • Berberine and its derivatives hold promise for cancer therapy.
  • Further investigation into toxicity and efficacy is warranted.
  • Potential for improved clinical outcomes in cancer treatment with enhanced safety profiles.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
600
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.5K